Liquid Crystals as Novel Drug Carrier: A Review

Authors

  • Nirmal Deshprabhu Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India
  • Charyulu R.N Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India
  • Mudit Dixit Department of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte University, Mangalore, Karnataka, India

DOI:

https://doi.org/10.37591/tdd.v2i1.271

Abstract

Liquid crystal is a thermodynamic stable phase characterized by anisotropic properties, generally lying in the temperature range between the solid and isotropic liquid phase, hence are termed mesophase. Based on the way that liquid crystals are obtained, they can be classified into two types—thermotropic liquid crystals and lyotropic liquid crystals. The thermotropic liquid crystal is generated by variation of temperature in the liquid state, while the lyotropic liquid crystal is formed by dissolving the compound in certain solvents. These primary phases are further sub-classified which will be discussed later. Recently, liquid crystals are studied as novel drug carrier systems. The reason for this interest is due to the extensive similarity of these colloidal systems to those in living organism and their superior advantageous properties over traditional dermal, parenteral and oral dosage forms. As research into this field continues and as new applications are developed, liquid crystals will play a vital role in modern technology. The purpose of this review is to focus on types, properties and applications of liquid crystals. Liquid crystals-based delivery systems such as creams, ointments, gels, liposomes, colloidal dispersions and transdermal patches have been used in pharmaceuticals and cosmetics. Liquid crystals have many applications in the fields of science, engineering and device technology. Liquid crystal-based systems can provide specific advantages of thermodynamic stability, high solubilisation levels, improved bioavailability, protection against oxidation and controlled release properties to the pharmaceuticals.

 

Keywords: Liquid Crystals, Mesophases, Thermotropic, Lyotropic, Drug Carrier

Downloads

Published

2019-02-21

Issue

Vol. 2 No. 1 (2015)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.